Physician profile
Robert Stephen Schoaps
NPI 1134546179
$54,271.07
in general payments reported to CMS, 2019-2025
8 companies · $38K in 2025
The $38K reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.38 · 2020: $57.09 · 2021: $80.18 · 2022: $107 · 2023: $625 · 2024: $15K · 2025: $38K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $41K · Travel and Lodging: $8,489 · Food and Beverage: $4,557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $40,950.00 |
| Travel and Lodging | $8,489.29 |
| Food and Beverage | $4,556.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $49,505.35 | 2020-2025 | 2nd Gen Centrimag Primary Console, Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $4,060.02 | 2020-2025 | Impella |
| Haemonetics Corporation | $407.91 | 2023-2024 | Teg6s Hemostasis System |
| Getinge USA Sales, LLC | $186.88 | 2020-2025 | Cardiohelp, Cardiohelp |
| La Jolla Pharmaceutical Company | $30.38 | 2019 | |
| Masimo Corporation | $29.41 | 2021 | |
| Merck Sharp & Dohme LLC | $28.88 | 2021-2022 | |
| Medtronic, INC. | $22.24 | 2023 | Trillium Affinity Nt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Schoaps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.